当期报告
NeuBase Therapeutics(NBSE)05-14 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接
简介:NeuBase Therapeutics, Inc.2009年8月4日在特拉华州注册。该是一家生物技术公司,使用一种新的合成药物加速基因革命。他们的模块化肽核酸反义寡核苷酸输出“反基因”候选疗法的平台旨在将基于基因序列的靶点识别的特异性与模块化相结合,该模块化允许使用各种体内递送技术来实现广泛且选择性的组织分布能力。考虑到每一种人类疾病都可能有遗传成分,他们的差异化平台技术具有广泛影响的潜力,通过增加、减少或改变DNA或RNA水平上的基因功能来解决特定适应症的疾病进展。
今开: | 昨收:0.378 |
最高: | 最低: |
涨停价: | 跌停价: |
总市值:1418101 |
NeuBase Therapeutics(NBSE)05-14 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接
NeuBase Therapeutics(NBSE)06-04 04:15
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-067779 Act: 34 Size: 943 KB 网页链接
NeuBase Therapeutics(NBSE)04-06 04:25
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001104659-24-044287 Act: 34 Size: 214 KB 网页链接
NeuBase Therapeutics(NBSE)05-14 18:05
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060759 Act: 34 Size: 18 KB 网页链接
NeuBase Therapeutics(NBSE)05-04 04:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-24-056957 Act: 34 Size: 206 KB 网页链接
NeuBase Therapeutics(NBSE)04-10 04:05
$NeuBase Therapeutics(NBSE)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-045207 Act: 34 Size: 1 MB 网页链接
NeuBase Therapeutics(NBSE)06-01 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-24-067212 Act: 34 Size: 291 KB 网页链接
NeuBase Therapeutics(NBSE)05-16 22:15
$NeuBase Therapeutics(NBSE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000350 Act: 34 Size: 3 KB 网页链接
NeuBase Therapeutics(NBSE)05-23 05:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-064320 Act: 34 Size: 211 KB 网页链接
NeuBase Therapeutics(NBSE)05-06 19:35
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-057213 Act: 34 Size: 19 KB 网页链接
药时代2022-10-20 14:32
前言
心理学告诉人们,永远不要在晚上做决定,因为那是不理性的。
但我不听劝(决定玩会手机),打开手机,又一则关于裁员的新闻弹出,让我陷入了思考。
我焦虑了,也失眠了。
新闻的题目是:“NeuBase放弃了亨廷顿舞蹈症,消减60%的劳动力作为战略支点”
还贴心附了...查看全文
LAES1682021-04-29 02:44
碗布斯2020-12-17 14:49
$NeuBase疗法(NBSE)$拿今年的利润满上搏一把查看全文
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-067779 Act: 34 Size: 943 KB 网页链接
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-24-067212 Act: 34 Size: 291 KB 网页链接
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-064320 Act: 34 Size: 211 KB 网页链接
$NeuBase Therapeutics(NBSE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000350 Act: 34 Size: 3 KB 网页链接
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060759 Act: 34 Size: 18 KB 网页链接
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-057213 Act: 34 Size: 19 KB 网页链接
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-24-056957 Act: 34 Size: 206 KB 网页链接
$NeuBase Therapeutics(NBSE)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-045207 Act: 34 Size: 1 MB 网页链接
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001104659-24-044287 Act: 34 Size: 214 KB 网页链接